Загрузка...
Persistence with dual antiplatelet therapy after percutaneous coronary intervention for ST-segment elevation acute coronary syndrome: a population-based cohort study in Catalonia (Spain)
OBJECTIVES: Guidelines recommending 12-month dual antiplatelet therapy (DAPT) in patients with ST-elevation acute coronary syndrome (STEACS) undergoing percutaneous coronary intervention (PCI) were published in year 2012. We aimed to describe the influence of guideline implementation on the trend in...
Сохранить в:
| Опубликовано в: : | BMJ Open |
|---|---|
| Главные авторы: | , , , , , , , , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BMJ Publishing Group
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6661631/ https://ncbi.nlm.nih.gov/pubmed/31340964 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2018-028114 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|